Our staff is standing by to help you. Click to chat.

Dr. Berman did not tell either Plaintiff that he used TRI-toxin rather than Botox for the injection.
Each Plaintiff alleges that when Dr. Berman administered the injections he represented that he was injecting them with Botox, and that he never disclosed that he was using the unapproved, unlicensed and less expensive TRI-toxin.
According to Judge Chamblen, the defendant tried to have the case dismissed on the grounds that his actions occured more than two years prior to the suit being filed. In fact, according to the opinion, they argued that the Plaintiffs should have, by the exercise of due diligence, discovered the alleged fraud by reading Internet articles in 2004 and newspaper articles in December 2004 and February 2005.
The court said:
I think that the allegations of each Complaint show that Dr. Berman's fraud, concealment and misrepresentation prevented each Plaintiff from discovering what he had actually injected into them until March and May 2007. Each filed suit within one year thereafter.
According to the Court's opinion, in May 2007 Dr. Berman pled guilty in United States District Court for the Eastern District of Virginia to introducing into interstate commerce a drug that was misbranded.